<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=234748540252369&amp;ev=PageView&amp;noscript=1">

Diopsys Insights

Ophthalmology Spotlight: How Patients Benefit from ERG Vision Testing

Posted by Diopsys, Inc. on March 29, 2018 at 8:49 AM

An Interview with William I. Bond, MD, FACS:

After over 40 years in practice, William I. Bond, MD has gotten fairly confident in his ability to evaluate a patient in the clinic and understand the health of the eye. 

The kind of knowledge that only comes from interacting with patients of all ages and vision disorders daily is a valuable tool when working with a new vision loss patient. It is what helps Dr. Bond look at a patient with a cataract, for example, and have an awareness that something else might be going on, perhaps something unseen that is affecting one or more parts of the complex human visual system. It may be that the degree of refractive change a patient is experiencing is more profound than what is suggested by the stage of the cataract. Yet, what that “something else” might be is not always obvious.

Read More

Topics: Pattern ERG, Flicker ERG

Retina Focus: How Do You Know if Treatment is Working?

Posted by William Ayliffe, FRCS, PHD on March 5, 2018 at 3:43 PM

The utility of objective, quantitative metrics for making treatment decisions.

INTRODUCTION:

Determining the effectiveness of treatment in a patient with suspected retinal pathology can be challenging. While visual acuity can serve as a benchmark, vision gains do not necessarily correlate with improvement in structure or global function. Despite the array of diagnostic modalities available to the eye care expert, very few of them deliver actionable information that is helpful in deciding if treatment is working, when to change course, or perhaps even when to cease treatment because risks outweigh the potential benefits.

Read More

Topics: Flicker ERG

Diabetic Retinopathy Management: An Advanced Approach

Posted by Alberto González García, M.D., Chief Medical Officer, Diopsys on February 1, 2018 at 9:43 AM

INTRODUCTION:

Patients with diabetic retinopathy can present difficult clinical questions, even to the most experienced experts. Whether and when to administer treatment and how to gauge effectiveness are topics that have been front and center in eye care for a long time. More fundamentally, understanding precisely how the disease is affecting the health of the eye has proven challenging, because while measurements like vision loss signify disease progression, visual acuity recovery after treatment does not necessarily correlate with improvement in underlying structure and function.

Read More

Topics: Flicker ERG, Diabetic Retinopathy

The Reason This Ophthalmologist Uses Flicker ERG

Posted by Mitchell A. Jackson, M.D. on December 9, 2016 at 3:09 AM

INTRODUCTION:

All of us anterior segment surgeons have coached our patients through the cataract surgery procedure and what type of vision they can expect when fully healed. The potential for diagnosing an existing retinopathy in patients with mild cataracts prior to surgery is relatively high. But predicting retinopathies and setting the proper patient expectations become more difficult when a dense cataract prohibits me from getting a reliable OCT or fundus photo. So what do I tell these patients? 

Now I have a reliable, objective test of retinal function that I can perform pre-operatively to give me an idea of what's going on behind the cataract. Flicker ERG has helped me ensure that these patients are accurately prepared for the outcome of their surgery. 

Read More

Topics: Flicker ERG

Modern Visual Electrophysiology

World Leading Technology

As the world leader in modern visual electrophysiology, Diopsys, Inc. has done more than any other company to advance the use of ERG and VEP in the eye care practice. Read through our blog to gain valuable insights into the benefits and integration of this valuable technology.

Subscribe to Email Updates

Recent Posts